Filing Flows › Collegium Pharmaceutical (COLL) › Free cash flow
Collegium Pharmaceutical (COLL) free cash flow by quarter
Collegium Pharmaceutical's free cash flow was $86.3M in Q3 2026 (third quarter 2026), +22% from Q2 2026. Over the last 7 quarters it ranged from $54.6M (Q1 2025) to $122M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $86.3M | +22% | +10% |
| Q2 2026 | $70.8M | +25% | -2% |
| Q1 2026 | $56.8M | -54% | +4% |
| Q4 2025 | $122M | +56% | — |
| Q3 2025 | $78.2M | +8% | — |
| Q2 2025 | $72.4M | +33% | — |
| Q1 2025 | $54.6M | — | — |
Q3 2026 at a glance
Collegium Pharmaceutical, Q3 2026: revenue $216M (+3% year over year), operating margin 13.3%, net earnings $21.8M, operating cash flow $86.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Collegium Pharmaceutical's free cash flow?
Collegium Pharmaceutical's free cash flow was $86.3M in Q3 2026 (third quarter 2026), +22% from Q2 2026.
How has Collegium Pharmaceutical's free cash flow changed?
Over the last 7 quarters it ranged from $54.6M (Q1 2025) to $122M (Q4 2025).
Q3 2026 results → · How Collegium Pharmaceutical makes money →